Janus Henderson Group’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-66,187
| Closed | -$93.7K | – | 2456 |
|
|
2025
Q1 | $93.7K | Hold |
66,187
| – | – | ﹤0.01% | 2461 |
|
|
2024
Q4 | $293K | Hold |
66,187
| – | – | ﹤0.01% | 2260 |
|
|
2024
Q3 | $272K | Hold |
66,187
| – | – | ﹤0.01% | 2311 |
|
|
2024
Q2 | $432K | Sell |
66,187
-790
| -1% | -$5.59K | ﹤0.01% | 2063 |
|
|
2024
Q1 | $583K | Buy |
66,977
+4
| +0% | +$49 | ﹤0.01% | 1936 |
|
|
2023
Q4 | $766K | Sell |
66,973
-109,515
| -62% | -$1.08M | ﹤0.01% | 1779 |
|
|
2023
Q3 | $1.7M | Sell |
176,488
-361,617
| -67% | -$3.54M | ﹤0.01% | 1276 |
|
|
2023
Q2 | $5.72M | Buy |
538,105
+471,054
| +703% | +$5.06M | ﹤0.01% | 825 |
|
|
2023
Q1 | $706K | Buy |
67,051
+43,245
| +182% | +$484K | ﹤0.01% | 1826 |
|
|
2022
Q4 | $295K | Sell |
23,806
-2
| -0% | -$23 | ﹤0.01% | 1984 |
|
|
2022
Q3 | $247K | Sell |
23,808
-89
| -0.4% | -$1.01K | ﹤0.01% | 1820 |
|
|
2022
Q2 | $276K | Sell |
23,897
-7,097
| -23% | -$83.6K | ﹤0.01% | 2127 |
|
|
2022
Q1 | $390K | Buy |
30,994
+10
| +0% | +$115 | ﹤0.01% | 2048 |
|
|
2021
Q4 | $361K | Buy |
30,984
+15,572
| +101% | +$191K | ﹤0.01% | 2100 |
|
|
2021
Q3 | $201K | Buy |
+15,412
| New | +$199K | ﹤0.01% | 2080 |
|
|
2020
Q4 | – | Sell |
-3,386,302
| Closed | -$30.5M | – | 1407 |
|
|
2020
Q3 | $30.5M | Buy |
3,386,302
+10,122
| +0.3% | +$101K | 0.02% | 618 |
|
|
2020
Q2 | $34.8M | Sell |
3,376,180
-3,840,044
| -53% | -$39.3M | 0.02% | 576 |
|
|
2020
Q1 | $72.8M | Sell |
7,216,224
-1,073,671
| -13% | -$12.6M | 0.05% | 355 |
|
|
2019
Q4 | $110M | Buy |
8,289,895
+888,863
| +12% | +$9.8M | 0.06% | 339 |
|
|
2019
Q3 | $63.5M | Sell |
7,401,032
-104,261
| -1% | -$1.01M | 0.03% | 504 |
|
|
2019
Q2 | $82.1M | Sell |
7,505,293
-438,314
| -6% | -$4.91M | 0.04% | 433 |
|
|
2019
Q1 | $90M | Sell |
7,943,607
-2,231
| -0% | -$24.9K | 0.05% | 408 |
|
|
2018
Q4 | $68.9M | Sell |
7,945,838
-1,590,371
| -17% | -$18.3M | 0.04% | 450 |
|
|
2018
Q3 | $147M | Sell |
9,536,209
-96,909
| -1% | -$1.53M | 0.08% | 299 |
|
|
2018
Q2 | $154M | Sell |
9,633,118
-70,864
| -0.7% | -$1.05M | 0.09% | 273 |
|
|
2018
Q1 | $125M | Sell |
9,703,982
-217,726
| -2% | -$2.71M | 0.07% | 318 |
|
|
2017
Q4 | $125M | Buy |
9,921,708
+437,581
| +5% | +$5.72M | 0.08% | 317 |
|
|
2017
Q3 | $125M | Sell |
9,484,127
-31,215
| -0.3% | -$430K | 0.08% | 303 |
|
|
2017
Q2 | $150M | Buy |
+9,515,342
| New | +$138M | 0.1% | 257 |
|
|
2015
Q3 | – | Sell |
-452,526
| Closed | -$4.57M | – | 847 |
|
|
2015
Q2 | $4.57M | Buy |
+452,526
| New | +$5.26M | 0.04% | 369 |
|
Other funds holding IRWD
AC
SCM
KCM
Janus Henderson Group's IRWD Position: Q2 2025 in Review
Janus Henderson Group sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 66,187 shares — an estimated $93.7K sold.
Janus Henderson Group first reported a position in IRWD in Q2 2015 and held it in 30 quarters. The position peaked at $154M in Q2 2018. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.
- Janus Henderson Group reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Janus Henderson Group sold 66,187 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $93.7K.
- Janus Henderson Group first reported a position in Ironwood Pharmaceuticals in Q2 2015 and held it in 30 quarters.
- Janus Henderson Group's Ironwood Pharmaceuticals position peaked at $154M in Q2 2018.
- 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.
Based on Janus Henderson Group's 13F filing for Q2 2025, filed 14 Aug 2025.